ArticleJournal of Taibah University Medical Sciences2026
Effects of alpha-pinene on depressive behaviors in a dextromethorphan-induced depression model in rats.
Article in Journal of Taibah University Medical Sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Depression, a multifactorial psychiatric disorder, affects millions of people worldwide and has limited effective therapeutic options. This study was aimed at investigating the potential antidepressant effects of alpha-pinene (aPI) in a dextromethorphan (DEX)-induced pharmacological model in rats. Methods: Thirty-two adult male Wistar rats were randomly assigned to four groups (n = 8). The control group received the vehicle (DMSO diluted in saline, 0.5 mL/kg, IP) for 14 days. The model group was administered DEX (40 mg/kg, IP) for 14 days to induce neurobehavioral alterations associated with depressive-like states. Two treatment groups received alpha-pinene (5 or 10 mg/kg, IP), which was dissolved in DMSO diluted in saline and administered 30 min before DEX injection for 14 days. Behavioral assessments, including the sucrose preference test, tail suspension test, and forced swimming test, were conducted to evaluate depressive-like behaviors. Hippocampal levels of TNF-α and MDA were measured with ELISA to assess neuroinflammation and oxidative stress. Results: DEX administration resulted in significant depressive-like behaviors, as evidenced by increased immobility in the forced swimming test and tail suspension test, and decreased sucrose preference (P < 0.001). Treatment with alpha-pinene (5 and 10 mg/kg) significantly ameliorated these behavioral alterations (P < 0.05), and no significant difference was observed between doses. Additionally, DEX significantly elevated hippocampal TNF-α and MDA levels, whereas alpha-pinene treatment markedly decreased these levels (P < 0.05). Conclusion: These findings suggest that alpha-pinene exerts antidepressant-like effects in a DEX-induced pharmacological model, potentially through modulation of neuroinflammatory and oxidative stress pathways. Nevertheless, confirmation in well-validated animal models of depression is required to strengthen the translational relevance of these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.